PINX1与TREM2变异与晚发性阿尔茨海默病的关联
该多中心队列研究对多种族人群进行全外显子组测序,采用跨种族基因核关联检验荟萃分析,发现PINX1(8p23.1)与晚发性阿尔茨海默病显著关联(P=2.81×10-6),并在复制队列中验证(P=6.16×10-7);TREM2在高 deleterious 变异注释模型中亦达显著(P=1.0×10-7)。
要点
- PINX1与TREM2是晚发性阿尔茨海默病的遗传易感位点。
- PINX1关联在家庭研究和国际阿尔茨海默遗传学项目中得到复制。
- 两基因均涉及衰老与神经退行性变过程。
核心结论
- 跨种族基因关联分析发现PINX1和TREM2与晚发性阿尔茨海默病相关。
研究设计与样本
- 多中心队列研究,发现队列3595人(1397例LOAD,2198例认知健康对照;女性2451人[68.2%];平均[SD]年龄80.3[6.83]岁)。
- 附加队列包括5931例LOAD和5504例对照,另在家庭研究和国际阿尔茨海默遗传学项目中复制。
主要发现
- 基因水平比较7328例患者与7702例对照,PINX1达基因宽显著(P=2.81×10-6)。
- PINX1在家庭研究和国际阿尔茨海默遗传学项目中得到复制,全荟萃分析P=6.16×10-7(7620例患者 vs 7768例对照)。
- TREM2在高 deleterious 变异注释模型(CADD>20)中显著(P=1.0×10-7)。
关键数值与推荐
- PINX1基因水平显著阈值P=2.81×10-6,复制后荟萃P=6.16×10-7。
- TREM2在CADD>20注释模型中P=1.0×10-7。
临床怎么用
- 提示PINX1和TREM2可作为LOAD遗传风险评估的候选基因。
- 为开发针对端粒完整性和小胶质细胞免疫受体的治疗靶点提供初步依据。
局限性
- 发现队列中321人(8.2%)因非LOAD诊断、年龄小于60岁、协变量缺失、重复数据或遗传离群被排除。
- 研究结果需在更多种族和更大样本中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Genetic causes of late-onset Alzheimer disease (LOAD) are not completely explained by known genetic loci. Whole-exome and whole-genome sequencing can improve the understanding of the causes of LOAD and provide initial steps required to identify potential therapeutic targets. OBJECTIVE: To identify the genetic loci for LOAD across different ethnic groups. DESIGN, SETTING, AND PARTICIPANTS: This multicenter cohort study was designed to analyze whole-exome sequencing data from a multiethnic cohort using a transethnic gene-kernel association test meta-analysis, adjusted for sex, age, and principal components, to identify genetic variants associated with LOAD. A meta-analysis was conducted on the results of 2 independent studies of whole-exome and whole-genome sequence data from individuals of European ancestry. This group of European American, African American, and Caribbean Hispanic individuals participating in an urban population-based study were the discovery cohort; the additional cohorts included affected individuals and control participants from 2 publicly available data sets. Replication was achieved using independent data sets from Caribbean Hispanic families with multiple family members affected by LOAD and the International Genetics of Alzheimer Project. MAIN OUTCOMES AND MEASURES: Late-onset Alzheimer disease. RESULTS: The discovery cohort included 3595 affected individuals, while the additional cohorts included 5931 individuals with LOAD and 5504 control participants. Of 3916 individuals in the discovery cohort, we included 3595 individuals (1397 with LOAD and 2198 cognitively healthy controls; 2451 [68.2%] women; mean [SD] age, 80.3 [6.83] years). Another 321 individuals (8.2%) were excluded because of non-LOAD diagnosis, age younger than 60 years, missing covariates, duplicate data, or genetic outlier status. Gene-based tests that compared affected individuals (n = 7328) and control participants (n = 7702) and included only rare and uncommon variants annotated as having moderate-high functional effect supported PINX1 (8p23.1) as a locus with gene-wide significance (P = 2.81 × 10-6) after meta-analysis across the 3 studies. The PINX1 finding was replicated using data from the family-based study and the International Genetics of Alzheimer Project. Full meta-analysis of discovery and replication cohorts reached a P value of 6.16 × 10-7 for PINX1 (in 7620 affected individuals vs 7768 control participants). We also identified TREM2 in an annotation model that prioritized highly deleterious variants with a combined annotation dependent depletion greater than 20 (P= 1.0 × 10-7). CONCLUSIONS AND RELEVANCE: This gene-based, transethnic approach identified PINX1, a gene involved in telomere integrity, and TREM2, a gene with a product of an immune receptor found in microglia, as associated with LOAD. Both genes have well-established roles in aging and neurodegeneration.
引用
- Tosto G, Vardarajan B, Sariya S, et al. Association of Variants in PINX1 and TREM2 With Late-Onset Alzheimer Disease. JAMA Neurol. 2019. PMID: 31058951. doi:10.1001/jamaneurol.2019.1066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。